The FUNDC1 Polyclonal Antibody (CAB16318) is a valuable tool for researchers studying the FUNDC1 protein, a key player in regulating mitophagy and cell survival. This antibody, generated in rabbits, exhibits high specificity and sensitivity when used in Western blot applications with human samples. By binding to FUNDC1, it enables the precise detection and analysis of this protein in a variety of cell types.FUNDC1, a mitochondrial outer membrane protein, is involved in maintaining mitochondrial homeostasis and quality control through selective autophagy. Its role in mitophagy, the process of degrading damaged mitochondria, makes it a crucial target for research into cell metabolism, aging, and neurodegenerative diseases.
Investigating the function of FUNDC1 can provide insights into the mechanisms underlying mitochondrial dysfunction and potential therapeutic strategies.Overall, the FUNDC1 Polyclonal Antibody offers researchers a reliable tool for studying the biology of FUNDC1 and its implications in various physiological and pathological conditions. Its versatility and specificity make it suitable for a wide range of research applications in cell biology and mitochondrial biology.
Product Name:
FUNDC1 Rabbit Polyclonal Antibody
SKU:
CAB16318
Size:
20uL, 100uL
Isotype:
IgG
Host Species:
Rabbit
Reactivity:
Human,Mouse
Immunogen:
A synthetic peptide corresponding to a sequence within amino acids 1-110 of human FUNDC1 (NP_776155.1).
This gene encodes a protein with a FUN14 superfamily domain. The function of the encoded protein is not known.
Purification Method:
Affinity purification
Gene ID:
139341
Storage Buffer:
Store at -20℃. Avoid freeze / thaw cycles.Buffer: PBS with 0.01% thimerosal,50% glycerol,pH7.3.
Western blot analysis of various lysates using FUNDC1 Rabbit pAb (CAB16318) at 1:1000 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (CABS014) at 1:10000 dilution.Lysates/proteins: 25μg per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Enhanced Kit (AbGn00021).Exposure time: 180s.
